Kobayashi Pharmaceutical will pay the medical bills of people who became ill after taking its troubled beni kōji fermented ...

A survey by an academic society has found that nearly 200 people in Japan had kidney function tests after taking supplements containing the "beni-koji" ingredient, or red yeast fermented rice.

The Food and Drug Administration (FDA) said that as of yesterday, it had received 58 reports of suspected adverse reactions ...

Recent quality scandals involving Japanese pharmaceutical companies have raised concerns among many Chinese tourists and business travelers who say such incidents may erode their trust in Japanese ...

More unexpected compounds have been found in some of Kobayashi Pharmaceutical's beni kōji (red yeast rice) supplements that are allegedly behind a series of health problems. The health ministry ...

Scandal-hit Kobayashi Pharmaceutical Co. announced April 25 it will begin covering the medical expenses of people who ...

TOKYO -- Sales of some Kobayashi Pharmaceutical products have plummeted 30% to 40% year-on-year after five deaths and other health problems were linked to the company's red yeast rice supplements ...

At least five deaths in Japan have been linked to health supplements made by Japanese drugmaker Kobayashi Pharmaceutical. More than 250 users have been hospitalized, with most cases involving kidney ...

The Osaka headquarters of The Yomiuri Shimbun, a Japanese national daily newspaper, on May 1 announced punishments for its ...

Most patients with kidney problems linked with Kobayashi Pharmaceutical Co. supplements are likely to have suffered from Fanconi syndrome, a kidney disorder, according to an ongoing investigation.

(Mainichi/Kazuhisa Soneda) OSAKA -- A reporter fabricated a source's comment regarding the ingredients in Kobayashi Pharmaceutical Co.'s "beni-koji" red yeast rice supplements, following a series ...